Trial Profile
Vascular function in impaired glucose tolerance - effect of pioglitazone
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Aug 2019
Price :
$35
*
At a glance
- Drugs Pioglitazone (Primary)
- Indications Glucose intolerance
- Focus Pharmacodynamics
- 02 Aug 2019 Status changed from recruiting to completed(Global end date : 2008-02-01)
- 01 Jun 2011 New trial record